RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/9053
https://w3id.org/ripe/ripe-kg/retraction-notice/9053
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEAF6F62EBFADD42DFB |
prov:used |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prism:doi |
10.1056/nejmx160005 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prism:publicationDate |
2016-03-10 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prism:publicationName |
NEJM: The New England Journal of Medicine |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
dcterms:publisher |
ripekg:publisher/RIPEP4BCC2B094139246FMassachusetts Medical Society |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
dcterms:title |
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1056%2Fnejmoa1407222 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
owl:Thing |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
owl:sameAs |
https://semopenalex.org/work/W4205903024 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF6F62EBFADD42DFB |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF6F62EBFADD42DFB |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
ripe:concerns |
ripekg:author/RIPEAUC085FD233B91326DPamela Shaw |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
ripe:concerns |
ripekg:work/10.1056%2Fnejmoa1407222 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
ripe:rationale |
Concerns/Issues about Referencing/Attributions;Error in Text;Legal Reasons and/or Threats |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
ripe:retractionWatchRecordId |
9053 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF6F62EBFADD42DFB-human-1-3 |
ripekg:retraction-notice/9053Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF6F62EBFADD42DFB-inspectai-1-3 |